• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用免疫印迹法测定天然抗体与不同脂多糖(LPS)反应性时出现的技术问题。

Technical problems arising from the use of the immunoblot for determination of the reactivity of natural antibodies with different lipopolysaccharides (LPS).

作者信息

Schoenherr G, Roggenbuck D, Seifert M, Jahn S, Porstmann T

机构信息

Department of Infectiology, Microbiology and Hygiene, Hospital Berlin-Buch, Berlin, Germany.

出版信息

J Immunol Methods. 1996 Apr 19;190(2):185-8. doi: 10.1016/0022-1759(95)00271-5.

DOI:10.1016/0022-1759(95)00271-5
PMID:8621953
Abstract

Natural polyreactive antibodies (NPAB) appear to play an important role in the first-line defence against invading bacteria. The major constituent of the outer membrane of Gram-negative bacteria is the lipopolysaccharide (LPS). Therefore, reactivity against this structure could be of importance in protecting the organism from the harmful effects of LPS. Immunoblotting has become a common method to verify the specificity of antigen antibody interactions. Various immunoblot techniques for testing the reactivity of monoclonal antibodies with LPS have been published using nitrocellulose and detergent-free blocking buffer systems. These methods are not suitable for the investigation of NPABs due to the broad reactivity and a high background staining which gives rise to interpretational difficulties. In the present study we demonstrate an immunoblot technique using polyvinylidene difluoride (PVDF) membranes and a detergent-containing buffer system which permits to detect LPS reactivity of NPABs. The polyreactive monoclonal human antibody CB03 used was screened for lipid A/LPS reactivity in ELISA experiments. The binding was confirmed in the described blot system and depends on the membranes and blocking agents used. The use of nitrocellulose versus PVDF was also tested for monospecific anti-LPS antibodies and the latter can be recommended due to the production of stronger reaction patterns without any background staining.

摘要

天然多反应性抗体(NPAB)似乎在抵御入侵细菌的一线防御中发挥着重要作用。革兰氏阴性菌外膜的主要成分是脂多糖(LPS)。因此,针对这种结构的反应性对于保护机体免受LPS的有害影响可能很重要。免疫印迹已成为验证抗原抗体相互作用特异性的常用方法。已经发表了各种使用硝酸纤维素和无去污剂封闭缓冲系统来检测单克隆抗体与LPS反应性的免疫印迹技术。由于NPAB具有广泛的反应性和高背景染色,会导致解释困难,因此这些方法不适用于NPAB的研究。在本研究中,我们展示了一种使用聚偏二氟乙烯(PVDF)膜和含去污剂缓冲系统的免疫印迹技术,该技术能够检测NPAB的LPS反应性。所使用的多反应性单克隆人抗体CB03在ELISA实验中进行了脂质A/LPS反应性筛选。在所述印迹系统中证实了结合,并且其取决于所用的膜和封闭剂。还对单特异性抗LPS抗体测试了硝酸纤维素与PVDF的使用情况,由于产生更强的反应模式且无任何背景染色,因此推荐使用后者。

相似文献

1
Technical problems arising from the use of the immunoblot for determination of the reactivity of natural antibodies with different lipopolysaccharides (LPS).使用免疫印迹法测定天然抗体与不同脂多糖(LPS)反应性时出现的技术问题。
J Immunol Methods. 1996 Apr 19;190(2):185-8. doi: 10.1016/0022-1759(95)00271-5.
2
Lipopolysaccharide epitope specificity and binding cross reactivity of the human IgM anti-lipid A monoclonal antibody SdJ5-1.17.15.人IgM抗脂质A单克隆抗体SdJ5-1.17.15的脂多糖表位特异性及结合交叉反应性
Mol Immunol. 1993 Jul;30(10):895-902. doi: 10.1016/0161-5890(93)90013-2.
3
Characterization of specific binding of a human immunoglobulin M monoclonal antibody to lipopolysaccharide and its lipid A domain.人免疫球蛋白M单克隆抗体与脂多糖及其脂质A结构域的特异性结合特性
Infect Immun. 1993 Mar;61(3):910-8. doi: 10.1128/iai.61.3.910-918.1993.
4
Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.抗大肠杆菌J5单克隆抗体与异源革兰氏阴性菌及提取的脂多糖的交叉反应性。
J Infect Dis. 1989 Nov;160(5):846-57. doi: 10.1093/infdis/160.5.846.
5
Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.人抗内毒素免疫球蛋白M单克隆抗体HA-1A与革兰氏阴性粗糙型及光滑型菌属脂多糖的反应活性。
Infect Immun. 1993 May;61(5):1756-63. doi: 10.1128/iai.61.5.1756-1763.1993.
6
Specificity and function of monoclonal antibodies reactive with discrete structural elements of bacterial lipopolysaccharide.与细菌脂多糖离散结构元件反应的单克隆抗体的特异性和功能。
Adv Exp Med Biol. 1990;256:331-40. doi: 10.1007/978-1-4757-5140-6_28.
7
[Generation and characterization of avian vitelline antibodies against lipopolysaccharide and lipid A. 2. Investigations of specificity of egg yolk antibodies (IgY) against endotoxin].[抗脂多糖和脂质A的禽卵黄抗体的产生及特性鉴定。2. 卵黄抗体(IgY)对内毒素特异性的研究]
Berl Munch Tierarztl Wochenschr. 1998 Apr;111(4):127-33.
8
Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides.针对脂质A和脂多糖的单克隆抗体及血清的交叉反应性。
Infection. 1993 May-Jun;21(3):179-86. doi: 10.1007/BF01710544.
9
Use of a zwitterionic detergent for the restoration of the antibody binding capacity of immunoblotted Francisella tularensis lipopolysaccharide.使用两性离子去污剂恢复免疫印迹的土拉弗朗西斯菌脂多糖的抗体结合能力。
Anal Biochem. 1992 May 15;203(1):141-5. doi: 10.1016/0003-2697(92)90054-b.
10
Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies.三种不同抗脂质A单克隆抗体的结合特性及交叉反应性
J Immunol. 1989 Dec 15;143(12):4053-60.

引用本文的文献

1
Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing.自身免疫性周围神经病及抗神经节苷脂/硫脂自身抗体检测的作用
Mediterr J Rheumatol. 2020 Mar 31;31(1):10-18. doi: 10.31138/mjr.31.1.10. eCollection 2020 Mar.
2
Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies.慢性炎症性脱髓鞘性多发性神经病的诊断见解
Ann Transl Med. 2018 Sep;6(17):337. doi: 10.21037/atm.2018.07.34.
3
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases.
通过线性免疫测定法检测的抗磷脂IgG抗体可区分抗磷脂综合征患者和其他自身免疫性疾病患者。
Auto Immun Highlights. 2018 May 29;9(1):6. doi: 10.1007/s13317-018-0106-0.
4
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.通过线性免疫测定法检测的抗磷脂抗体可区分抗磷脂综合征患者、感染患者和无症状携带者。
Arthritis Res Ther. 2016 May 21;18(1):111. doi: 10.1186/s13075-016-1018-x.